P Karayiannis
Overview
Explore the profile of P Karayiannis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
127
Citations
1698
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Alexopoulou A, Karayiannis P
Aliment Pharmacol Ther
. 2018 Jun;
48(1):102-103.
PMID: 29882982
No abstract available.
2.
Karayiannis P
Hepatol Int
. 2017 Nov;
11(6):500-508.
PMID: 29098564
Hepatitis B virus is a member of the Hepadnaviridae family and responsible for causing acute and chronic hepatitis in humans. The current estimates of people chronically infected with the virus...
3.
Foster G, Afdhal N, Karayiannis P, Thursz M
J Viral Hepat
. 2014 Dec;
22(1):1.
PMID: 25535958
No abstract available.
4.
Baltayiannis G, Karayiannis P
J Viral Hepat
. 2014 Oct;
21(11):753-61.
PMID: 25271858
Chronic hepatitis B virus (HBV) infection may progress to cirrhosis, hepatocellular carcinoma (HCC) and end-stage liver failure with time. Interruption of this process can only be achieved through effective antiviral...
5.
Luo K, Liu Z, Karayiannis P
J Viral Hepat
. 2009 Oct;
17(7):511-7.
PMID: 19818003
Alpha-fetoprotein (AFP) is a marker of the presence of hepatocellular carcinoma (HCC), but is also elevated in advanced chronic hepatitis B. The detection and usage of AFP tests need to...
6.
Zois C, Baltayiannis G, Karayiannis P, Tsianos E
Aliment Pharmacol Ther
. 2008 Sep;
28(10):1175-87.
PMID: 18761707
Background: Hepatic fibrosis occurs in response to chronic liver injury, regardless of the cause. An impressive amount of knowledge concerning the pathogenesis and treatment of liver fibrosis has emerged over...
7.
Luo K, Mao Q, Karayiannis P, Liu D, Liu Z, Zhou Y, et al.
J Viral Hepat
. 2008 Jun;
15(9):684-9.
PMID: 18554243
The response to interferon-alpha treatment of patients with chronic hepatitis B under the current protocol is not satisfactory. The aim of this study was to try an alternative approach to...
8.
Alexopoulou A, Theodorou M, Dourakis S, Karayiannis P, Sagkana E, Papanikolopoulos K, et al.
J Viral Hepat
. 2006 Aug;
13(9):591-6.
PMID: 16907845
Hepatitis B virus (HBV) strains carrying the precore stop-codon mutation (A1896) have been considered among the predisposing factors for reactivation during chemotherapy for malignancies. The role of the T1762/A1764 basic...
9.
Baltayiannis G, Katsanos K, Karayiannis P, Tsianos E
Aliment Pharmacol Ther
. 2006 Aug;
24(3):525-33.
PMID: 16886919
Aims: To determine the long-term response to interferon-alpha therapy in patients with hepatitis B e antigen-negative chronic hepatitis B, and the factors independently associated with response and survival. Methods: Sixty-three...
10.
The hepatitis C virus NS3/4A protease complex interferes with pathways of the innate immune response
Karayiannis P
J Hepatol
. 2005 Aug;
43(4):743-5.
PMID: 16102870
No abstract available.